The medical technology company Odinwell states that the board, management and the major owner Nestero Holding have undertaken to exercise their warrants of series TO 2, corresponding to approximately 5.2 million warrants or 12 percent of the total outstanding warrants. The subscription period runs from May 18 to June 1. Upon full exercise at the highest subscription price, the company can receive approximately SEK 2.5 million before costs.Odinwell has Carlsquare as advisor.